Last reviewed: June 10, 2026
Last updated: June 10, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Ozempic, reduces hunger signals in the brain and slows stomach emptying, creating conditions for meaningful weight loss. Research from the STEP trials demonstrated that people using semaglutide lost significantly more weight than those on diet and exercise alone—but individual results vary based on genetics, lifestyle, and medication dose escalation.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
Average Semaglutide Weight Loss in Clinical Trials
The landmark STEP 1 trial followed 1,961 adults with obesity over 68 weeks and found that those taking semaglutide lost an average of 14.9 kg (about 33 pounds), compared to 2.6 kg in the placebo group. Participants at the highest dose achieved weight reductions of 15–22% of their starting body weight. These results represent some of the most substantial weight-loss outcomes ever documented in obesity research.
Weight loss typically accelerates during the first 4–8 weeks as the body adjusts to the medication's appetite-suppressing effects. Most people continue losing weight steadily through weeks 16–20, then experience a plateau as their metabolism adapts. Maintaining the prescribed dose and consistent lifestyle habits—like balanced nutrition and movement—helps sustain losses long-term rather than regaining weight after treatment.
Individual Factors That Influence Your Weight Loss Outcome
The PlexusDx Precision Peptide Genetic Test analyzes FTO — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
Lifestyle factors matter just as much as the medication itself. People who combine semaglutide with regular physical activity, adequate protein intake, and stress management consistently achieve better results than those relying on medication alone. Dose escalation also influences outcomes—starting at lower doses and gradually increasing allows your body to tolerate the medication while building toward the most effective therapeutic dose for your metabolism.
How Semaglutide Compares to Other Weight-Loss Medications
Semaglutide belongs to a class called GLP-1 receptor agonists, which mimic a natural hormone that regulates appetite and blood sugar. Clinical evidence shows semaglutide produces superior weight loss compared to older medications like phentermine or older GLP-1 drugs—up to 15–22% body weight reduction versus 5–10% for earlier-generation options. Newer dual-action medications like tirzepatide (which combines GLP-1 and GIP signaling) may achieve slightly higher weight loss in some populations, but semaglutide remains a highly effective, well-studied first-line choice.
The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
Accessing Semaglutide Without the Ozempic Price Tag
Brand-name Ozempic typically costs $900–$1,500 per month through insurance, and many plans deny coverage or require prior authorization. PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies at $189/mo month-to-month, or from $149/mo on the 6-month plan—a fraction of brand pricing—without requiring insurance or membership fees. Your dose may need to go up as your body adapts, but your price won't: flat monthly pricing means no surprise cost jumps as you adjust toward your optimal therapeutic dose.
PlexusDx serves all 50 states and makes semaglutide eligible for HSA and FSA accounts, further reducing out-of-pocket costs. The Precision Peptide Genetic Test ($298) helps ensure you're on the right medication from the start, potentially saving months of trial-and-error adjustments and unnecessary expenses. Combined with telehealth convenience and personalized dosing protocols, PlexusDx makes evidence-based semaglutide therapy accessible to anyone serious about sustainable weight loss.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.
Frequently Asked Questions
How fast will I lose weight on semaglutide?
Most people notice reduced hunger within days and begin losing weight within 1–2 weeks. Steady, consistent weight loss typically occurs over the first 8–16 weeks, with an average loss of 1–2 pounds per week once you reach your therapeutic dose. Individual speed depends on your metabolism, starting weight, and how closely you follow dosing and lifestyle guidance.
What does the clinical research say about long-term weight loss?
The STEP trials followed participants for 68 weeks and showed sustained weight loss without plateauing, with no indication of rebound weight gain during active treatment. A 3-year follow-up study found that people who continued semaglutide maintained their weight loss, while those who stopped treatment gradually regained about two-thirds of the weight they'd lost.
How much does semaglutide cost at PlexusDx, and do I need insurance?
PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan with no insurance required and no membership fees. Pricing remains flat regardless of dose level, and treatment is eligible for HSA and FSA accounts, making it accessible to most patients seeking effective weight-loss therapy.
What are the common side effects, and do they affect weight loss?
Common side effects include nausea, vomiting, constipation, and decreased appetite—most mild and temporary during the first 2–4 weeks. These effects don't reduce semaglutide's weight-loss effectiveness; in fact, the appetite suppression is the mechanism that drives fat loss. Your prescribing provider at PlexusDx will adjust your dose if side effects become bothersome.
How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?
No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Ozempic and ADHD: Does Semaglutide Interact With ADHD Medications?
Semaglutide and Fatty Liver Disease: Can You Take Ozempic with This Condition?